These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33089434)

  • 1. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis.
    Navarrete C; Garcia-Martin A; DeMesa J; Muñoz E
    Curr Hypertens Rep; 2020 Oct; 22(12):98. PubMed ID: 33089434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
    Karimian Azari E; Kerrigan A; O'Connor A
    J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils.
    Komarnytsky S; Rathinasabapathy T; Wagner C; Metzger B; Carlisle C; Panda C; Le Brun-Blashka S; Troup JP; Varadharaj S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.
    Velayudhan L; Van Diepen E; Marudkar M; Hands O; Suribhatla S; Prettyman R; Murray J; Baillon S; Bhattacharyya S
    Curr Pharm Des; 2014; 20(13):2218-30. PubMed ID: 23829360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
    Cairns EA; Toguri JT; Porter RF; Szczesniak AM; Kelly ME
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):253-65. PubMed ID: 26565550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
    Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
    Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
    Horváth B; Mukhopadhyay P; Haskó G; Pacher P
    Am J Pathol; 2012 Feb; 180(2):432-42. PubMed ID: 22155112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation.
    Mastinu A; Premoli M; Ferrari-Toninelli G; Tambaro S; Maccarinelli G; Memo M; Bonini SA
    Horm Mol Biol Clin Investig; 2018 Mar; 36(2):. PubMed ID: 29601300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids: A Guide for Use in the World of Gastrointestinal Disease.
    Unal E; Anderson B; Helber A; Marks JH
    J Clin Gastroenterol; 2020 Oct; 54(9):769-788. PubMed ID: 31789770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder.
    Chu L; Shu Z; Gu X; Wu Y; Yang J; Deng H
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):445-463. PubMed ID: 36745405
    [No Abstract]   [Full Text] [Related]  

  • 14. Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain.
    Toguri JT; Caldwell M; Kelly ME
    Front Pharmacol; 2016; 7():304. PubMed ID: 27695415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in the Cardiovascular System.
    Ho WSV; Kelly MEM
    Adv Pharmacol; 2017; 80():329-366. PubMed ID: 28826540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk.
    Khan RN; Maner-Smith K; A Owens J; Barbian ME; M Jones R; R Naudin C
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33896380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.
    Bright U; Akirav I
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
    Di Carlo G; Izzo AA
    Expert Opin Investig Drugs; 2003 Jan; 12(1):39-49. PubMed ID: 12517253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
    Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E
    Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.